Winston Lee1, Jana Zernant1, Takayuki Nagasaki1, Stephen H Tsang1, Rando Allikmets2. 1. Department of Ophthalmology, Columbia University, New York, New York, USA. 2. Department of Ophthalmology, Columbia University, New York, New York, USA; Department of Pathology & Cell Biology, Columbia University, New York, New York, USA. Electronic address: rla22@cumc.columbia.edu.
Abstract
PURPOSE: To describe a distinct phenotypic outcome of outer retinal degeneration in a cohort of genetically confirmed patients with recessive Stargardt disease (STGD1). DESIGN: Retrospective case series. METHODS: Twelve patients, who were clinically diagnosed with STGD1 and exhibited a unique degenerative phenotype, were included in the study. Two disease-causing mutations were found in all patients by direct sequencing of the ABCA4 gene. Clinical characterization of patients were defined on fundus photographs, autofluorescence images (488-nm and 532-nm excitation), spectral-domain optical coherence tomography (SD-OCT), and full-field electroretinogram (ffERG) testing. RESULTS: Mean age at initial presentation was 67.8 years and reported age of symptomatic onset was 14.1 years (mean disease duration = 53.8 years). Best-corrected visual acuity ranged from 20/400 to hand motion. All patients exhibited advanced degeneration across the posterior pole resulting in a reflectively pale, blonde fundus owing to unobstructed exposure of the underlying sclera. SD-OCT revealed complete loss of the outer retinal bands (external limiting membrane, ellipsoid zone, interdigitation zone, and retinal pigment epithelium) and choroidal layers. Scotopic and photopic waveforms on ffERG were nonrecordable or severely attenuated in 8 patients who were tested. CONCLUSIONS: Widespread scleral exposure is a clinical outcome in a subset of STGD1 following a long duration of disease progression (∼50 years). The blonde fundus in such cases may exhibit phenotypic overlap and shared therapeutic implications with other aggressive chorioretinal dystrophies such as end-stage choroideremia, gyrate atrophy, or RPE65-Leber congenital amaurosis.
PURPOSE: To describe a distinct phenotypic outcome of outer retinal degeneration in a cohort of genetically confirmed patients with recessive Stargardt disease (STGD1). DESIGN: Retrospective case series. METHODS: Twelve patients, who were clinically diagnosed with STGD1 and exhibited a unique degenerative phenotype, were included in the study. Two disease-causing mutations were found in all patients by direct sequencing of the ABCA4 gene. Clinical characterization of patients were defined on fundus photographs, autofluorescence images (488-nm and 532-nm excitation), spectral-domain optical coherence tomography (SD-OCT), and full-field electroretinogram (ffERG) testing. RESULTS: Mean age at initial presentation was 67.8 years and reported age of symptomatic onset was 14.1 years (mean disease duration = 53.8 years). Best-corrected visual acuity ranged from 20/400 to hand motion. All patients exhibited advanced degeneration across the posterior pole resulting in a reflectively pale, blonde fundus owing to unobstructed exposure of the underlying sclera. SD-OCT revealed complete loss of the outer retinal bands (external limiting membrane, ellipsoid zone, interdigitation zone, and retinal pigment epithelium) and choroidal layers. Scotopic and photopic waveforms on ffERG were nonrecordable or severely attenuated in 8 patients who were tested. CONCLUSIONS: Widespread scleral exposure is a clinical outcome in a subset of STGD1 following a long duration of disease progression (∼50 years). The blonde fundus in such cases may exhibit phenotypic overlap and shared therapeutic implications with other aggressive chorioretinaldystrophies such as end-stage choroideremia, gyrateatrophy, or RPE65-Leber congenital amaurosis.
Authors: Wener Cella; Vivienne C Greenstein; Jana Zernant-Rajang; Theodore R Smith; Gaetano Barile; Rando Allikmets; Stephen H Tsang Journal: Exp Eye Res Date: 2009-02-13 Impact factor: 3.467
Authors: A Martínez-Mir; E Paloma; R Allikmets; C Ayuso; T del Rio; M Dean; L Vilageliu; R Gonzàlez-Duarte; S Balcells Journal: Nat Genet Date: 1998-01 Impact factor: 38.330
Authors: F P Cremers; D J van de Pol; M van Driel; A I den Hollander; F J van Haren; N V Knoers; N Tijmes; A A Bergen; K Rohrschneider; A Blankenagel; A J Pinckers; A F Deutman; C B Hoyng Journal: Hum Mol Genet Date: 1998-03 Impact factor: 6.150
Authors: Vera L Bonilha; Karmen M Trzupek; Yong Li; Peter J Francis; Joe G Hollyfield; Mary E Rayborn; Nizar Smaoui; Richard G Weleber Journal: Ophthalmic Genet Date: 2008-09 Impact factor: 1.803
Authors: Artur V Cideciyan; Tomas S Aleman; Malgorzata Swider; Sharon B Schwartz; Janet D Steinberg; Alexander J Brucker; Albert M Maguire; Jean Bennett; Edwin M Stone; Samuel G Jacobson Journal: Hum Mol Genet Date: 2004-01-06 Impact factor: 6.150
Authors: Hui Y Xiong; Babak Alipanahi; Leo J Lee; Hannes Bretschneider; Daniele Merico; Ryan K C Yuen; Yimin Hua; Serge Gueroussov; Hamed S Najafabadi; Timothy R Hughes; Quaid Morris; Yoseph Barash; Adrian R Krainer; Nebojsa Jojic; Stephen W Scherer; Benjamin J Blencowe; Brendan J Frey Journal: Science Date: 2014-12-18 Impact factor: 47.728
Authors: Shinya Yamamoto; Manish Jaiswal; Wu-Lin Charng; Tomasz Gambin; Ender Karaca; Ghayda Mirzaa; Wojciech Wiszniewski; Hector Sandoval; Nele A Haelterman; Bo Xiong; Ke Zhang; Vafa Bayat; Gabriela David; Tongchao Li; Kuchuan Chen; Upasana Gala; Tamar Harel; Davut Pehlivan; Samantha Penney; Lisenka E L M Vissers; Joep de Ligt; Shalini N Jhangiani; Yajing Xie; Stephen H Tsang; Yesim Parman; Merve Sivaci; Esra Battaloglu; Donna Muzny; Ying-Wooi Wan; Zhandong Liu; Alexander T Lin-Moore; Robin D Clark; Cynthia J Curry; Nichole Link; Karen L Schulze; Eric Boerwinkle; William B Dobyns; Rando Allikmets; Richard A Gibbs; Rui Chen; James R Lupski; Michael F Wangler; Hugo J Bellen Journal: Cell Date: 2014-09-25 Impact factor: 66.850
Authors: Jana Zernant; Winston Lee; Jun Wang; Kerry Goetz; Ehsan Ullah; Takayuki Nagasaki; Pei-Yin Su; Gerald A Fishman; Stephen H Tsang; Santa J Tumminia; Brian P Brooks; Robert B Hufnagel; Rui Chen; Rando Allikmets Journal: PLoS Genet Date: 2022-03-30 Impact factor: 5.917